Clinical Trials for Thrombocytopenia, Neonatal Alloimmune

Find clinical trials for thrombocytopenia, neonatal alloimmune. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT ID: NCT06449651

This clinical trial is studying a medication called nipocalimab to see if it can help reduce the risk of a condition known as fetal and neonatal alloimmune thrombocytopenia (FNAIT) in pregnant wome...

Recruiting

Phase: PHASE3 Type: interventional Locations: Ljubljana, Slovenia, Trondheim, Norway +18 more

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT ID: NCT06533098

This clinical trial is studying a treatment called nipocalimab to see if it can help reduce the risk of a serious condition known as fetal and neonatal alloimmune thrombocytopenia (FNAIT) during pr...

Recruiting

Phase: PHASE3 Type: interventional Locations: Hannover, Germany, Oxford, United Kingdom +11 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions